負債 変化する 日付
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Chugai Pharma JPY 14.11B 1.93B 2022-12
Daiichi Sankyo JPY 500.48B 200B 2026-06
DBV Technologies USD 7.5M 1.4M 2026-09
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Glaxosmithkline GBP 23.7B 4.65B 2026-09
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Novavax USD 233.31M 4.23M 2024-09
PTC Therapeutics USD 2.84B 2.15B 2026-09
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09